Secondary Faculty

Dhruv Satish Kazi

Associate Professor in the Department of Epidemiology

Epidemiology, Harvard T.H. Chan School of Public Health

Departments

Department of Epidemiology

Other Positions

Associate Professor of Medicine

Medicine-Beth Israel Deaconess, Harvard Medical School

Biography

Glucagon-like peptide 1 receptor agonists and venous thromboembolism in type 2 diabetes: a target trial emulation.

Chiang CH, Song J, Chang YC, Osataphan S, Lee YC, Chang KY, Chi KY, Chiang CH, Dua A, Lake L, Lauw MN, Bauer KA, Kazi DS, Patell R. Blood Adv 2025 May 27

PMID: 39908569
The Limitations and Risks Associated With Semaglutide Treatment-Reply.

Shi I, Khan SS, Kazi DS. JAMA Cardiol 2025 May 14

PMID: 40366706
Periconceptional Glucagon-Like Peptide-1 Receptor Agonist Use and Discontinuation.

Khan SS, Grobman WA, Kazi DS. JAMA Cardiol 2025 Apr 16

PMID: 40238124
Prototyping and Manufacturing of Customized Over-Encapsulated Polypills for Heart Failure With Reduced Ejection Fraction in a Safety-Net Health Care System.

Dejong C, Durstenfeld MS, Davis JD, Wang CS, Chen JC, Kazi DS, Hickey MD, Grochowski J, Steward WT, Riley ED, Zier LS, Moreau N, Huffman MD, Sandhu AT, Heidenreich PA, Agarwal A, Hsue PY. J Card Fail 2025

PMID: 40169092
Validation of Medicare Advantage Claims for Long-Term Outcome Assessment in Low-Risk Aortic Valve Replacement.

Lalani C, Medina F, Oseran AS, Liang L, Song Y, Butala NM, Kazi DS, Cohen DJ, Strom JB, Wadhera RK, Yeh RW. Circ Cardiovasc Qual Outcomes 2025

PMID: 40156581

In addition to our degree programs, we offer highly targeted executive and continuing education, directed and taught by Harvard faculty.